Literature DB >> 34192271

What can neuroimmunology teach us about the symptoms of long-COVID?

Valeria Mondelli1,2, Carmine M Pariante1,2.   

Abstract

Long-Coronavirus Disease (Long-COVID) is becoming increasingly recognized due to the persistence of symptoms such as profound fatigue, neurocognitive difficulties, muscle pains and weaknesses and depression, which would last beyond 3-12 weeks following infection with SARS-CoV-2. These particular symptoms have been extensively observed and studied in the context of previous psychoneuroimmunology research. In this short commentary, we discuss how previous neuroimmunology studies could help us to better understand pathways behind the development of these prolonged symptoms. Various mechanisms, including viral neuroinvasion, glial cells activation, neurogenesis, oxidative stress have been shown to explain these symptoms in the context of other disorders. Previous neuroimmunology findings could represent helpful pointers for future research on long-COVID symptoms and suggest potential management strategies for patients suffering with long-COVID.
© The Author(s) 2021. Published by Oxford University Press.

Entities:  

Keywords:  COVID-19; depression; fatigue; long-COVID; microglia; neuroimmunology

Year:  2021        PMID: 34192271      PMCID: PMC7928677          DOI: 10.1093/oxfimm/iqab004

Source DB:  PubMed          Journal:  Oxf Open Immunol        ISSN: 2633-6960


  56 in total

Review 1.  Inflammation-associated depression: from serotonin to kynurenine.

Authors:  Robert Dantzer; Jason C O'Connor; Marcus A Lawson; Keith W Kelley
Journal:  Psychoneuroendocrinology       Date:  2010-10-30       Impact factor: 4.905

Review 2.  Chronic fatigue syndrome and circulating cytokines: A systematic review.

Authors:  S Blundell; K K Ray; M Buckland; P D White
Journal:  Brain Behav Immun       Date:  2015-07-03       Impact factor: 7.217

3.  Depression, dementia and immune dysregulation.

Authors:  Shawn Hayley; Antoine M Hakim; Paul R Albert
Journal:  Brain       Date:  2021-04-12       Impact factor: 13.501

Review 4.  Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors.

Authors:  David Baumeister; Alice Russell; Carmine M Pariante; Valeria Mondelli
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-01       Impact factor: 4.328

5.  Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.

Authors:  Jonathan P Rogers; Edward Chesney; Dominic Oliver; Thomas A Pollak; Philip McGuire; Paolo Fusar-Poli; Michael S Zandi; Glyn Lewis; Anthony S David
Journal:  Lancet Psychiatry       Date:  2020-05-18       Impact factor: 27.083

6.  Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.

Authors:  R Bernard-Valnet; B Pizzarotti; A Anichini; Y Demars; E Russo; M Schmidhauser; J Cerutti-Sola; A O Rossetti; R Du Pasquier
Journal:  Eur J Neurol       Date:  2020-05-30       Impact factor: 6.089

7.  Interferon-alpha-Induced Changes in NODDI Predispose to the Development of Fatigue.

Authors:  N G Dowell; S Bouyagoub; J Tibble; V Voon; M Cercignani; N A Harrison
Journal:  Neuroscience       Date:  2017-12-29       Impact factor: 3.590

Review 8.  Inflammation in cancer and depression: a starring role for the kynurenine pathway.

Authors:  Luca Sforzini; Maria Antonietta Nettis; Valeria Mondelli; Carmine Maria Pariante
Journal:  Psychopharmacology (Berl)       Date:  2019-02-26       Impact factor: 4.530

9.  Neuroinvasion of SARS-CoV-2 in human and mouse brain.

Authors:  Eric Song; Ce Zhang; Benjamin Israelow; Alice Lu-Culligan; Alba Vieites Prado; Sophie Skriabine; Peiwen Lu; Orr-El Weizman; Feimei Liu; Yile Dai; Klara Szigeti-Buck; Yuki Yasumoto; Guilin Wang; Christopher Castaldi; Jaime Heltke; Evelyn Ng; John Wheeler; Mia Madel Alfajaro; Etienne Levavasseur; Benjamin Fontes; Neal G Ravindra; David Van Dijk; Shrikant Mane; Murat Gunel; Aaron Ring; Syed A Jaffar Kazmi; Kai Zhang; Craig B Wilen; Tamas L Horvath; Isabelle Plu; Stephane Haik; Jean-Leon Thomas; Angeliki Louvi; Shelli F Farhadian; Anita Huttner; Danielle Seilhean; Nicolas Renier; Kaya Bilguvar; Akiko Iwasaki
Journal:  J Exp Med       Date:  2021-03-01       Impact factor: 17.579

10.  Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.

Authors:  Neil A Harrison; Lena Brydon; Cicely Walker; Marcus A Gray; Andrew Steptoe; Hugo D Critchley
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382

View more
  9 in total

1.  Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 Conditions.

Authors:  Siwen Wang; Luwei Quan; Jorge E Chavarro; Natalie Slopen; Laura D Kubzansky; Karestan C Koenen; Jae Hee Kang; Marc G Weisskopf; Westyn Branch-Elliman; Andrea L Roberts
Journal:  JAMA Psychiatry       Date:  2022-09-07       Impact factor: 25.911

Review 2.  Post-COVID-19 Condition: Where Are We Now?

Authors:  Paula Boaventura; Sofia Macedo; Filipa Ribeiro; Sónia Jaconiano; Paula Soares
Journal:  Life (Basel)       Date:  2022-03-31

Review 3.  Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C.

Authors:  Claudia Vollbracht; Karin Kraft
Journal:  Front Pharmacol       Date:  2022-04-29       Impact factor: 5.988

4.  Post-Covid-19 Syndrome: Improvements in Health-Related Quality of Life Following Psychology-Led Interdisciplinary Virtual Rehabilitation.

Authors:  Sari Harenwall; Suzanne Heywood-Everett; Rebecca Henderson; Sherri Godsell; Sarah Jordan; Angela Moore; Ursula Philpot; Kirsty Shepherd; Joanne Smith; Amy Rachel Bland
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

5.  'I can't cope with multiple inputs': a qualitative study of the lived experience of 'brain fog' after COVID-19.

Authors:  Caitriona Callan; Emma Ladds; Laiba Husain; Kyle Pattinson; Trisha Greenhalgh
Journal:  BMJ Open       Date:  2022-02-11       Impact factor: 2.692

6.  Who Is at Risk of Poor Mental Health Following Coronavirus Disease-19 Outpatient Management?

Authors:  Katharina Hüfner; Piotr Tymoszuk; Dietmar Ausserhofer; Sabina Sahanic; Alex Pizzini; Verena Rass; Matyas Galffy; Anna Böhm; Katharina Kurz; Thomas Sonnweber; Ivan Tancevski; Stefan Kiechl; Andreas Huber; Barbara Plagg; Christian J Wiedermann; Rosa Bellmann-Weiler; Herbert Bachler; Günter Weiss; Giuliano Piccoliori; Raimund Helbok; Judith Loeffler-Ragg; Barbara Sperner-Unterweger
Journal:  Front Med (Lausanne)       Date:  2022-03-14

7.  Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms.

Authors:  Grace Kenny; Kathleen McCann; Conor O'Brien; Stefano Savinelli; Willard Tinago; Obada Yousif; John S Lambert; Cathal O'Broin; Eoin R Feeney; Eoghan De Barra; Peter Doran; Patrick W G Mallon
Journal:  Open Forum Infect Dis       Date:  2022-03-07       Impact factor: 3.835

Review 8.  Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders.

Authors:  Raina Rhoades; Sarah Solomon; Christina Johnson; Shaolei Teng
Journal:  Front Microbiol       Date:  2022-04-04       Impact factor: 6.064

9.  Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study).

Authors:  Shamil Haroon; Krishnarajah Nirantharakumar; Sarah E Hughes; Anuradhaa Subramanian; Olalekan Lee Aiyegbusi; Elin Haf Davies; Puja Myles; Tim Williams; Grace Turner; Joht Singh Chandan; Christel McMullan; Janet Lord; David C Wraith; Kirsty McGee; Alastair K Denniston; Thomas Taverner; Louise J Jackson; Elizabeth Sapey; George Gkoutos; Krishna Gokhale; Edward Leggett; Clare Iles; Christopher Frost; Gary McNamara; Amy Bamford; Tom Marshall; Dawit T Zemedikun; Gary Price; Steven Marwaha; Nikita Simms-Williams; Kirsty Brown; Anita Walker; Karen Jones; Karen Matthews; Jennifer Camaradou; Michael Saint-Cricq; Sumita Kumar; Yvonne Alder; David E Stanton; Lisa Agyen; Megan Baber; Hannah Blaize; Melanie Calvert
Journal:  BMJ Open       Date:  2022-04-26       Impact factor: 3.006

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.